Location History:
- Tokushima, JP (1994 - 1996)
- Naruto, JP (2019)
Company Filing History:
Years Active: 1994-2019
Title: Kazuo Hino: Innovator in Nutritional and Diagnostic Solutions
Introduction
Kazuo Hino, an inventive mind hailing from Tokushima, Japan, has made significant contributions to the fields of nutrition and diagnostics through his innovative patents. With a total of three patents to his name, Hino stands out as a notable inventor, particularly within the pharmaceutical landscape.
Latest Patents
Two of his latest patents exhibit his commitment to advancing health-related technology. The first patent, titled "Diarrhea-preventing nutritional composition," outlines a nutritional formulation designed to prevent diarrhea while enabling effective administration of necessary nutritional ingredients. This composition is crafted using a specifically selected pectin that can maintain viscosity in liquid form, ensuring stability and efficacy.
Hino's second patent, "Anti-EDA monoclonal antibody and a method for diagnosis of disease," introduces a monoclonal antibody that recognizes a unique amino acid sequence in the EDA region of fibronectin (FN). This invention proposes a novel immunoassay method for EDA-FN, which can facilitate high-sensitivity and high-precision diagnostics for inflammatory and other diseases associated with EDA-FN.
Career Highlights
Kazuo Hino is currently affiliated with Otsuka Pharmaceutical Factory, Inc., a company known for its commitment to innovative health solutions. His research and development efforts have not only contributed to the company’s portfolio but have also enhanced healthcare options available to individuals.
Collaborations
Throughout his career, Hino has collaborated with esteemed colleagues, including Kaneji Asakawa and Eiji Sakashita. These partnerships have fostered a dynamic research environment, enabling the development of groundbreaking technologies in the pharmaceutical space.
Conclusion
Kazuo Hino's innovative contributions in the areas of nutritional compositions and diagnostic antibodies represent a significant advancement in healthcare. His patents not only showcase his inventive capabilities but also highlight the potential for improved health outcomes through scientific innovation. The ongoing efforts of Hino and his collaborators at Otsuka Pharmaceutical Factory, Inc. continue to pave the way for future developments in the field.